Market revenue in 2023 | USD 94.6 million |
Market revenue in 2030 | USD 172.1 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Reagents & consumables |
Fastest growing segment | Reagents & Consumables |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Reagents & Consumables, Software & Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Qiagen NV, Illumina Inc, Becton Dickinson & Co, Takara Bio Inc, Roche Holding AG ADR, Pacific Biosciences of California Inc, Omixon, TBG Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hla typing market will help companies and investors design strategic landscapes.
Reagents & consumables was the largest segment with a revenue share of 54.55% in 2023. Horizon Databook has segmented the Asia Pacific hla typing market based on instruments, reagents & consumables, software & services covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific hla typing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific hla typing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account